CoChat
Sign Up
Cited by 401

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Glioblastoma Stem Cells: Driving Resilience through Chaos

Prager, Briana C., Bhargava, Shruti, Mahadev, Vaidehi, Hubert, Christopher G., Rich, Jeremy N.·2020·Trends in Cancer
DOI 10.1016/j.trecan.2020.01.009PMC PMC8779821
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trecan.2020.01.009

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 12 references

Research works printed but not linked: 103

  1. Omuro, 2013, Glioblastoma and other malignant gliomas: a clinical review, JAMA, 310, 1842, 10.1001/jama.2013.280319 · DOI
  2. Wang, 2016, Clonal evolution of glioblastoma under therapy, Nat. Genet., 48, 768, 10.1038/ng.3590 · DOI · Paper page
  3. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  4. Wang, 2017, Tumor evolution of blioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment, Cancer Cell, 32, 42, 10.1016/j.ccell.2017.06.003 · DOI
  5. Lathia, 2015, Cancer stem cells in glioblastoma, Genes Dev., 29, 1203, 10.1101/gad.261982.115 · DOI · Paper page
  6. Singh, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res., 63, 5821
  7. Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 · DOI
  8. Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236 · DOI
  9. Chen, 2013, ADAM17 promotes U87 glioblastoma stem cell migration and invasion, Brain Res., 1538, 151, 10.1016/j.brainres.2013.02.025 · DOI
  10. Cheng, 2011, Elevated invasive potential of glioblastoma stem cells, Biochem. Biophys. Res. Commun., 406, 643, 10.1016/j.bbrc.2011.02.123 · DOI
  11. Liu, 2006, Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Mol. Cancer, 5, 67, 10.1186/1476-4598-5-67 · DOI
  12. Covello, 2006, HIF-2 regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth, Genes Dev., 20, 557, 10.1101/gad.1399906 · DOI
  13. Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle Georget. Tex., 8, 3274, 10.4161/cc.8.20.9701 · DOI · Paper page
  14. Seidel, 2010, A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2, Brain., 133, 983, 10.1093/brain/awq042 · DOI
  15. Tafani, 2011, Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma, J. Neuroinflammation, 8, 32, 10.1186/1742-2094-8-32 · DOI
  16. Lee, 2006, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, Cancer Cell, 9, 391, 10.1016/j.ccr.2006.03.030 · DOI
  17. Son, 2009, SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma, Cell Stem Cell, 4, 440, 10.1016/j.stem.2009.03.003 · DOI
  18. Chen, 2010, A hierarchy of self-renewing tumor-initiating cell types in glioblastoma, Cancer Cell, 17, 362, 10.1016/j.ccr.2009.12.049 · DOI
  19. Dirks, 2010, Brain tumor stem cells: the cancer stem cell hypothesis writ large, Mol. Oncol., 4, 420, 10.1016/j.molonc.2010.08.001 · DOI
  20. Lan, 2017, Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy, Nature., 549, 227, 10.1038/nature23666 · DOI
  21. Neftel, 2019, An integrative model of cellular states, plasticity, and genetics for glioblastoma, Cell., 178, 835, 10.1016/j.cell.2019.06.024 · DOI · Paper page
  22. Sottoriva, 2013, Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics, Proc. Natl. Acad. Sci., 110, 4009, 10.1073/pnas.1219747110 · DOI · Paper page
  23. West, 2012, Differential network entropy reveals cancer system hallmarks, Sci. Rep., 2, 802, 10.1038/srep00802 · DOI
  24. Dirkse, 2019, Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment, Nat. Commun., 10, 1787, 10.1038/s41467-019-09853-z · DOI
  25. Banerji, 2013, Cellular network entropy as the energy potential in Waddington’s differentiation landscape, Sci. Rep., 3, 3039, 10.1038/srep03039 · DOI
  26. Chang, 2008, Transcriptome-wide noise controls lineage choice in mammalian progenitor cells, Nature., 453, 544, 10.1038/nature06965 · DOI
  27. Furusawa, 2009, Chaotic expression dynamics implies pluripotency: when theory and experiment meet, Biol. Direct, 4, 17, 10.1186/1745-6150-4-17 · DOI
  28. Leder, 2014, Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules, Cell., 156, 603, 10.1016/j.cell.2013.12.029 · DOI
  29. Furusawa, 2012, A dynamical-systems view of stem cell biology, Science., 338, 215, 10.1126/science.1224311 · DOI
  30. Teschendorff, 2014, Signalling entropy: a novel network-theoretical framework for systems analysis and interpretation of functional omic data, Methods., 67, 282, 10.1016/j.ymeth.2014.03.013 · DOI
  31. Nguyen, 2012, Cancer stem cells: an evolving concept, Nat. Rev. Cancer, 12, 133, 10.1038/nrc3184 · DOI
  32. Furusawa, 2001, Theory of robustness of irreversible differentiation in a stem cell system: chaos hypothesis, J. Theor. Biol., 209, 395, 10.1006/jtbi.2001.2264 · DOI
  33. MacArthur, 2013, Statistical mechanics of pluripotency, Cell., 154, 484, 10.1016/j.cell.2013.07.024 · DOI
  34. Pisco, 2013, Non-Darwinian dynamics in therapy-induced cancer drug resistance, Nat. Commun., 4, 2467, 10.1038/ncomms3467 · DOI
  35. Miller, 2017, Transcription elongation factors represent in vivo cancer dependencies in glioblastoma, Nature, 547, 355, 10.1038/nature23000 · DOI · Paper page
  36. Creixell, 2012, Navigating cancer network attractors for tumor-specific therapy, Nat. Biotechnol., 30, 842, 10.1038/nbt.2345 · DOI
  37. Harutyunyan, 2019, H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis, Nat. Commun., 10, 1262, 10.1038/s41467-019-09140-x · DOI
  38. Jin, 2017, Targeting glioma stem cells through combined BMI1 and EZH2 inhibition, Nat. Med., 23, 1352, 10.1038/nm.4415 · DOI
  39. Chu, 2018, Chromatin run-on and sequencing maps the transcriptional regulatory landscape of glioblastoma multiforme, Nat. Genet., 50, 1553, 10.1038/s41588-018-0244-3 · DOI
  40. Mack, 2019, Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma, J. Exp. Med., 216, 1071, 10.1084/jem.20190196 · DOI
  41. Carén, 2015, Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest, Stem Cell Rep., 5, 829, 10.1016/j.stemcr.2015.09.014 · DOI
  42. Gupta, 2011, Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells, Cell., 146, 633, 10.1016/j.cell.2011.07.026 · DOI · Paper page
  43. Hardee, 2012, Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β, Cancer Res., 72, 4119, 10.1158/0008-5472.CAN-12-0546 · DOI
  44. Rao, 2012, CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma, PLoS One, 7, 10.1371/journal.pone.0033005 · DOI
  45. Zhu, 2011, Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells, Cancer Res., 71, 6061, 10.1158/0008-5472.CAN-10-4269 · DOI
  46. Charles, 2010, Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells, Cell Stem Cell, 6, 141, 10.1016/j.stem.2010.01.001 · DOI · Paper page
  47. Brooks, 2013, Hitting them where they live: targeting the glioblastoma perivascular stem cell niche, Curr. Pathobiol. Rep., 1, 101, 10.1007/s40139-013-0012-0 · DOI
  48. Becher, 2008, Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas, Cancer Res., 68, 2241, 10.1158/0008-5472.CAN-07-6350 · DOI
  49. Krusche, 2016, EphrinB2 drives perivascular invastion and proliferation of glioblastoma stem-like cells, eLife, 5, 10.7554/eLife.14845 · DOI
  50. Jain, 2007, Angiogenesis in brain tumours, Nat. Rev. Neurosci., 8, 610, 10.1038/nrn2175 · DOI
  51. Cheng, 2013, Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth, Cell., 153, 139, 10.1016/j.cell.2013.02.021 · DOI · Paper page
  52. Durham, 2014, Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics, AJP Cell Physiol., 307, C878, 10.1152/ajpcell.00185.2014 · DOI
  53. El Hallani, 2010, A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry, Brain., 133, 973, 10.1093/brain/awq044 · DOI
  54. Hu, 2016, Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth, Cell., 167, 1281, 10.1016/j.cell.2016.10.039 · DOI
  55. Ricci-Vitiani, 2010, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, Nature., 468, 824, 10.1038/nature09557 · DOI
  56. Batchelor, 2014, Antiangiogenic therapy for glioblastoma: current status and future prospects, Clin. Cancer Res., 20, 5612, 10.1158/1078-0432.CCR-14-0834 · DOI
  57. DeLay, 2012, Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy, Clin. Cancer Res., 18, 2930, 10.1158/1078-0432.CCR-11-2390 · DOI
  58. Qiang, 2012, HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway, Cell Death Differ., 19, 284, 10.1038/cdd.2011.95 · DOI · Paper page
  59. Moreno-Manzano, 2010, FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status, J. Biol. Chem., 285, 1333, 10.1074/jbc.M109.008326 · DOI
  60. Joseph, 2015, Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α–ZEB1 axis, Cancer Lett., 359, 107, 10.1016/j.canlet.2015.01.010 · DOI
  61. Marampon, 2014, Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay, Int. J. Oncol., 44, 2121, 10.3892/ijo.2014.2358 · DOI
  62. Ortensi, 2013, Cancer stem cell contribution to glioblastoma invasiveness, Stem Cell Res Ther, 4, 18, 10.1186/scrt166 · DOI
  63. Cheng, 2011, L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1: L1CAM regulates checkpoint of GBM stem cells, EMBO J., 30, 800, 10.1038/emboj.2011.10 · DOI
  64. Carro, 2010, The transcriptional network for mesenchymal transformation of brain tumours, Nature., 463, 318, 10.1038/nature08712 · DOI
  65. Goffart, 2015, Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling, Neuro-Oncol., 17, 81, 10.1093/neuonc/nou144 · DOI
  66. Sherry, 2009, STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells, Stem Cells Dayt. Ohio, 27, 2383, 10.1002/stem.185 · DOI · Paper page
  67. Velpula, 2012, Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway, Cell. Signal., 24, 2076, 10.1016/j.cellsig.2012.07.002 · DOI
  68. Herrera-Perez, 2015, Extracellular matrix properties regulate the migratory response of glioblastoma stem cells in three-dimensional culture, Tissue Eng. Part A, 21, 2572, 10.1089/ten.tea.2014.0504 · DOI
  69. Cosset, 2016, Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness, Biomaterials., 107, 74, 10.1016/j.biomaterials.2016.08.009 · DOI
  70. Hubert, 2016, A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo, Cancer Res., 76, 2465, 10.1158/0008-5472.CAN-15-2402 · DOI
  71. Herting, 2017, Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas, Glia., 65, 1914, 10.1002/glia.23203 · DOI
  72. Ceccarelli, 2016, Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma, Cell., 164, 550, 10.1016/j.cell.2015.12.028 · DOI
  73. Fiorenzo, 2010, HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo, Int. J. Oncol., 36, 785
  74. Ouchi, 2016, Senescence from glioma stem cell differentiation promotes tumor growth, Biochem. Biophys. Res. Commun., 470, 275, 10.1016/j.bbrc.2016.01.071 · DOI
  75. Reinartz, 2016, Functional subclone profiling for prediction of treatment-induced intra-tumor population shifts and discovery of rational drug combinations in human glioblastoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 23, 562, 10.1158/1078-0432.CCR-15-2089 · DOI
  76. Soeda, 2015, The evidence of glioblastoma heterogeneity, Sci. Rep., 5, 7979, 10.1038/srep07979 · DOI
  77. Meyer, 2015, Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity, Proc. Natl. Acad. Sci., 112, 851, 10.1073/pnas.1320611111 · DOI
  78. Lottaz, 2010, Transcriptional profiles of CD133+ and CD133− glioblastoma-derived cancer stem cell lines suggest different cells of origin, Cancer Res., 70, 2030, 10.1158/0008-5472.CAN-09-1707 · DOI
  79. Lathia, 2010, Integrin alpha 6 regulates glioblastoma stem cells, Cell Stem Cell, 6, 421, 10.1016/j.stem.2010.02.018 · DOI
  80. Rasper, 2010, Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity, Neuro-Oncol., 12, 1024, 10.1093/neuonc/noq070 · DOI
  81. Jin, 2013, Cell surface nestin is a biomarker for glioma stem cells, Biochem. Biophys. Res. Commun., 433, 496, 10.1016/j.bbrc.2013.03.021 · DOI
  82. Annovazzi, 2011, SOX2 expression and amplification in gliomas and glioma cell lines, Cancer Genomics Proteomics, 8, 139
  83. Ligon, 2007, Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma, Neuron., 53, 503, 10.1016/j.neuron.2007.01.009 · DOI
  84. Zbinden, 2010, NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53, EMBO J., 29, 2659, 10.1038/emboj.2010.137 · DOI
  85. Kauffman, 1971, Differentiation of malignant to benign cells, J. Theor. Biol., 31, 429, 10.1016/0022-5193(71)90020-8 · DOI
  86. Suvà, 2014, Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells, Cell., 157, 580, 10.1016/j.cell.2014.02.030 · DOI
  87. Auffinger, 2014, Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy, Cell Death Differ., 21, 1119, 10.1038/cdd.2014.31 · DOI
  88. Orzan, 2017, Genetic evolution of glioblastoma stem-like cells from primary to recurrent tumor: genetic evolution of glioblastoma stem-like cells, Stem Cells, 35, 2218, 10.1002/stem.2703 · DOI
  89. Flavahan, 2013, Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake, Nat. Neurosci., 16, 1373, 10.1038/nn.3510 · DOI
  90. Schonberg, 2015, Preferential iron trafficking characterizes glioblastoma stem-like cells, Cancer Cell, 28, 441, 10.1016/j.ccell.2015.09.002 · DOI
  91. Negrini, 2010, Genomic instability – an evolving hallmark of cancer, Nat. Rev. Mol. Cell Biol., 11, 220, 10.1038/nrm2858 · DOI · Paper page
  92. Peng, 2016, The error-prone DNA polymerase promotes temozolomide resistance in glioblastoma through Rad17-dependent activation of ATR–Chk1 signaling, Cancer Res., 76, 2340, 10.1158/0008-5472.CAN-15-1884 · DOI
  93. Tentori, 2014, Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide, BMC Cancer, 14, 10.1186/1471-2407-14-151 · DOI
  94. Wang, 2010, Notch promotes radioresistance of glioma stem cells, Stem Cells, 28, 17, 10.1002/stem.261 · DOI
  95. Ahmed, 2015, Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells, Cancer Res., 75, 4416, 10.1158/0008-5472.CAN-14-3790 · DOI
  96. Rheinbay, 2013, An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma, Cell Rep., 3, 1567, 10.1016/j.celrep.2013.04.021 · DOI
  97. Vlashi, 2011, Metabolic state of glioma stem cells and nontumorigenic cells, Proc. Natl. Acad. Sci., 108, 16062, 10.1073/pnas.1106704108 · DOI
  98. Bhat, 2013, Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma, Cancer Cell, 24, 331, 10.1016/j.ccr.2013.08.001 · DOI
  99. Tejero, 2019, Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment, EBioMedicine., 42, 252, 10.1016/j.ebiom.2019.03.064 · DOI
  100. Sachdeva, 2019, BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma, Sci. Rep., 9, 10.1038/s41598-019-51270-1 · DOI
  101. Chinot, 2014, Bevacizumab plus padiotherapy–temozolomide for newly diagnosed glioblastoma, N. Engl. J. Med., 370, 709, 10.1056/NEJMoa1308345 · DOI
  102. Wick, 2017, Lomustine and bevacizumab in progressive glioblastoma, N. Engl. J. Med., 377, 1954, 10.1056/NEJMoa1707358 · DOI
  103. Lu, 2013, Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma, CNS Oncol., 2, 49, 10.2217/cns.12.36 · DOI

Cited by

Sorted by citations

See all 401

Metadata

Authors
Prager, B. C., Bhargava, S., Mahadev, V., Hubert, C. G., & Rich, J. N.
Venue
Trends in Cancer
Publisher
Elsevier BV
Published
2020-03
Volume
6
Issue
3
Pages
223-235
ISSN
2405-8033
DOI
10.1016/j.trecan.2020.01.009
PMC
PMC8779821
Cited by
401
References
12
Language
en
Licence
Funders
National Institutes of Health (NS103434, CA217066, CA197718, CA238662)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review